Bill Ackman Will Be on CNBC's Halftime Report Today (VRX) (HLF)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Herbalife (HLF) Has 'Levers to Pull' in Next Few Weeks - Pivotal Research
July 18, 2016 9:40 AM EDTPivotal Research reiterated a Buy rating on Herbalife (NYSE: HLF) with a price target of $90. Analyst Timothy S. Ramey doesn't believe efforts to comply with FTC oversight will do much damage to its U.S. business, and he reiterated his bullish stance. He also noted that Herbalife has "several important levers to pull in the next few weeks."
"There is no doubt that the permanent injunction, entered into by the FTC and Herbalife has challenges for the company and plenty of stern language. The company will be under three-year scrutiny by the... More
Herbalife (HLF) Enters Settlement with FTC; Board Grants Icahn Ability to Boost Stake to 34.99%
July 15, 2016 8:28 AM EDTHerbalife Ltd. (NYSE: HLF) announced it has reached a settlement agreement with the Federal Trade Commission (FTC or the Commission) resolving the FTCs multi-year investigation of the Company. The terms of the settlement do not change Herbalifes business model as a direct selling company and set new standards for the industry. With the settlement agreement announced today, the FTCs investigation of Herbalife is complete.
Herbalife and the Illinois Attorney General also reached a settlement, and the Company agreed to pay $3 million as part of this separate agreement. With the conclusion of the... More
Valeant (VRX) Investors Should Be Focused on Earnings Not Upcoming Product Catalysts - Wells Fargo
July 14, 2016 1:29 PM EDTWhile Valeant Pharmaceuticals (NYSE: VRX) continues to avoid trading on fundamentals three potential catalysts lie ahead for the company. Today, Wells Fargo bearish-leaning analyst David Maris provide his thoughts ahead of these events.
The 3 events are:
Friday (7/15) advisory panel documents should become available ahead of next Tuesdays (7/19) FDA advisory panel on brodalumab;next... MoreAckman Made a 'Valiant' Effort, Time to Move On: Herbalife (HLF)
July 14, 2016 12:13 PM EDTIn a statement read on CNBC, Herbalife (NYSE: HLF) said Ackman made a 'valiant' on his short effort but it's time to move one. Clearly a stab at his blow-up in Valeant (VRX).
... MoreValeant Pharma (VRX) Shares Rise After Clarifying Recent Pearson Stock, Options Sales
July 14, 2016 9:00 AM EDTValeant Pharma (NYSE: VRX) shares are indicated higher in early trading Thursday after the company issued commentary on recent stock transactions conducted by former CEO Mike Pearson. The stock is up over 3 percent.
... More